2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Experimental Ischemia and Reperfusion Injury

111.3 - Augmentation of hepatic ischemia/reperfusion (I/R) injury in liver grafts lacking PD-L1 expression

Presenter: Shoko, Kimura, Pittsburgh, United States
Authors: Ueki S., Castellaneta A., Yoshida O., Ozaki K., Zhang M., Kimura S., Thomson A., Geller D., Murase N.

AUGMENTATION OF HEPATIC ISCHEMIA/REPERFUSION (I/R) INJURY IN LIVER GRAFTS LACKING PD-L1 EXPRESSION

EXPERIMENTAL ISCHEMIA AND REPERFUSION INJURY

S. Ueki1, A. Castellaneta1, O. Yoshida1, K.S. Ozaki2, M. Zhang1, S. Kimura3, A.W. Thomson4, D. Geller1, N. Murase5
1Surgery - University Of Pittsburgh, Thomas E Starzl Transplantation Institute, Pittsburgh/PA/UNITED STATES OF AMERICA, 2Surgery - University Of Pittsburgh, Thomas E. Starzl Transplantation Institute, Pittsburgh/PA/UNITED STATES OF AMERICA, 3E1505 Biomedical Science Tower, University of Pittsburgh Thomas E Starzl Transplantation Institute, Pittsburgh/PA/UNITED STATES OF AMERICA, 4Surgery, Thomas Starzl Transplantation Institute, Pittsburgh/PA/UNITED STATES OF AMERICA, 5Surgery, University of Pittsburgh Medical Center, Pittsburgh/UNITED STATES OF AMERICA

Body: Background: I/R injury remains as a significant risk factor contributing to high mortality and morbidity after liver transplantation (LTx). The programmed death 1 (PD-1) receptor and its ligand PD-L1 are known to play an important role in regulating local immune responses. We hypothesize that the PD-L1 pathway plays crucial roles during innate immune responses induced by hepatic I/R injury. The hypothesis was directly tested in the mouse LTx model using PD-L1 KO grafts. Methods: PD-L1 KO or WT B6 liver grafts were transplanted into B6 CD45.1 recipients after 24 hrs cold preservation in UW solution. Recipients were sacrificed 1-24 hrs after LTx, and liver grafts were analyzed by immunohistochemistry, PCR, and FACs after collagenase digestion and hepatic NPC isolation. Results: Prolonged cold storage resulted in significant hepatic injury in WT grafts with ALT levels 5759 U/L and numerous necrotic foci at 12 hrs, which associated with prompt PD-L1 induction on hepatocytes, in addition to enhanced constitutive PD-L1 expression on sinusoidal endothelial cells and DC. The injury was significantly augmented in PD-L1 KO grafts with significantly increased T cells in immunohistochemistry, and ICAM and MCP-I mRNA upregulation. FACs of hepatic NPC further revealed significant increases of CD69+ CD8 T cells in KO graft. PD-L1 KO grafts had significantly lower Annexin V+ cells among infiltrating CD8+ T cells, indicating the failure to delete infiltrating CD8+ T cells during I/R injury. Further, to determine if parenchymal or NPC PD-L1 expression regulated innate inflammatory infiltrates, liver grafts lacking PD-L1 on parenchyma or on NPC were created and transplanted into B6 CD45.1 mice. Selective PD-L1 deficiency on patrnchyma or NPC resulted in higher levels of ALT (~6600 U/L) and CD8+ T cell infiltrates compared to WT grafts. However, frequencies of Annexin V+ CD8+ T cells were lower when PD-L1 was deficient in parenchyma than in BM-derived cells (27 vs 46%), suggesting rather significant function of parenchyma PD-L1 in deleting CD8+ T cells, although PD-L1 expression on both parenchyma and NPC plays important roles in I/R injury. Conclusions: The study demonstrates that graft tissue expression of PD-L1 plays a critical role in regulating inflammatory responses during LTx-induced hepatic I/R injury, and suggests that negative regulatory costimulatory signals may have an important function in innate immune responses.

Liver graft ALT (U/L) 12 hr ICAM mRNA MCP-1 mRNA %CD3+ T cells in CD45+NPC %CD69+ in CD8+ T cells %Annexin V+ in CD8+ T cells
WT 5759±417 7.3±1.1 197.6±14.1 3% 58% 42%
KO 9500±1248* 14.4±0.3 433.6±43.4 21% 80% 20%

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada